SCHEMBL1500705

SCHEMBL1500705

CCCC[Sn](CCCC)(CCCC)c1nnn(-c2cccc(C)c2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 3/20 0.41
LMNA P02545 5/20 0.40
TP53 P04637 1/20 0.40
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
POLB P06746 2/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1500675 0.87 IDO1 (0.38) ALDH1A1MAPTLMNATP53IDO1
SCHEMBL1500668 0.86 TP53 (0.45) ALDH1A1MAPTTP53POLBTSHR
SCHEMBL1500749 0.83 LMNA (0.38) ALDH1A1L3MBTL1MAPTLMNATP53
SCHEMBL1500709 0.81 GRM1 (0.46) L3MBTL1IDO1TDO2CYP3A4TDP1
SCHEMBL1500679 0.78 PTGS2 (0.46) ALDH1A1L3MBTL1MAPTLMNATP53
SCHEMBL1500674 0.77
SCHEMBL1500690 0.77 NPC1 (0.39) TP53
SCHEMBL1500670 0.76
SCHEMBL1500684 0.76 ALDH1A1 (0.39) ALDH1A1L3MBTL1MAPTLMNATP53
SCHEMBL1500694 0.75 TP53 (0.41) ALDH1A1MAPTTP53TSHRAPLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110160208-A1 DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-06-30 US disclosed
US-7902369-B2 Diaryl-substituted five-membered heterocycle derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070173507-A1 Dairyl-substituted five-membered heterocycle derivative MSD K.K. (JP) 2007-07-26 US disclosed
EP-1726585-A1 DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160208-A1 DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE OPRK1, GRM1, GRIK1 ALDH1A1 1200/4885L3MBTL1 1655/4885MAPT 2711/4885
US-20070173507-A1 Dairyl-substituted five-membered heterocycle derivative OPRK1, OPRL1, GRM1 ALDH1A1 1033/4885L3MBTL1 1278/4885MAPT 2182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.